Brief: Strides Pharma Science Sept-Quarter Consol Net Profit 1.28 Billion Rupees
31/10/2025 07:50
Oct 31 (Reuters) - Strides Pharma Science Ltd SRID.NS: SEPT-QUARTER CONSOL NET PROFIT 1.28 BILLION RUPEES SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 12.21 BILLION RUPEES Source text: [ID:] Further company coverage: SRID.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees